Enzyme-responsive nanocomposites for wound infection prophylaxis in burn management: In vitro evaluation of their compatibility with healing processes

Keyphrases

• Healing Process 100%
• In Vitro Evaluation 100%
• Wound Infection 100%
• Infection Prophylaxis 100%
• Burn Management 100%
• Enzyme-responsive 100%
• Nanoparticles 66%
• Nanocapsules 66%
• Endothelial Cells 33%
• Antimicrobial 33%
• Antibacterial Biomaterials 33%
• Nanosystems 33%
• Long-term Exposure 33%
• Wound Healing 33%
• Inflammatory Cells 33%
• Flow Cytometric Analysis 33%
• Enzyme-linked Immunosorbent Assay (ELISA) 33%
• Human Dermal Microvascular Endothelial Cells (HDMECs) 33%
• Cell Adhesion Molecules 33%
• Angiogenic 33%
• Nanocarriers 33%
• Theranostic Nanoplatform 33%
• Cytotoxicity Test 33%
• Capillary Structure 33%
• Dye Molecules 33%
• Bacterial Enzymes 33%
• Biguanides 33%
• Antiseptic Agents 33%
• Cutaneous Wound Healing 33%
• Drug Exposure 33%
• Poly(L-lactic acid) 33%
• Dermal Fibroblasts 33%
• Hyaluronan 33%
• Crystal Violet Assay 33%
• Dressing Change 33%
• Advanced Drug Delivery Systems 33%
• Polyhexanide 33%
• Anti-infective Drugs 33%
• Octenidine 33%
• Burn Wound Treatment 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Burn 100%
• Antiinfective Agent 100%
• Nanocomposite 100%
• Wound Infection 100%
• Nanoparticle 66%
• Side Effect 66%
• Wound Healing 66%
• Nanocapsule 66%
• Infectious Agent 33%
• Drug Delivery System 33%
• Cytotoxicity 33%
• Nanocarrier 33%
• Enzyme Immunoassay 33%
• Infection 33%
• Cytokine 33%
• Long Term Exposure 33%
• Hyaluronic Acid 33%
• Skin Injury 33%
• Lactic Acid 33%
• Bacterial Enzyme 33%
• Octenidine 33%
• Cell Adhesion Molecule 33%
• Crystal Violet 33%
• Biguanide 33%